Home

Woodline Partners reported a 8.1% stake in Zevra Therapeutics ZVRA · 4,785,771 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
8.1%
Last report
6.2% · filed 25/11/14
Shares held
4,785,771 sh
Class
Common Stock, par value $0.0001 per share
Event date
26/06/30
Filed
26/08/14

8.1% stake · +1.9pp from the last report

Stake
8.1%
Last report
6.2%
Since last report
+1.9pp

Zevra Therapeutics trades, last 26 weeks

What else happened in Zevra Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Woodline Partners's other 5% stake reports

  • Woodline Partners

    5% stakeTango Therapeutics

    2.5% stake

    Filed 08/14

  • Woodline Partners

    5% stakeSAB Biotherapeutics

    6.8% stake

    Filed 08/14

  • Woodline Partners

    5% stakeCervoMed

    5.1% stake

    Filed 08/14

  • Woodline Partners

    5% stakeCalciMedica

    8.1% stake

    Filed 08/14

  • Woodline Partners

    5% stakeBlack Rock Coffee Bar

    0% stake

    Filed 08/14